Xilio Therapeutics issues 6.86M shares to Gilead at $1.97/share for $13.5M private placement

Xilio Therapeutics, Inc.

Closed private placement of 6,860,223 shares to Gilead Sciences at $1.97/share for ~$13.5M.
Shares issued under an exclusive license agreement previously disclosed.
Shares outstanding increased from 27,613,263 to 34,473,486.
Placement closed on March 28, 2024, as part of strategic collaboration with Gilead.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.